David Southwell
2021
In 2021, David Southwell earned a total compensation of $2.8M as Former President, Chief Executive Officer and Director at TScan Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $310,449 |
|---|---|
| Option Awards | $1,923,650 |
| Salary | $564,452 |
| Other | $8,935 |
| Total | $2,807,486 |
Southwell received $1.9M in option awards, accounting for 69% of the total pay in 2021.
Southwell also received $310.4K in non-equity incentive plan, $564.5K in salary and $8.9K in other compensation.
Rankings
In 2021, David Southwell's compensation ranked 4,685th out of 12,415 executives tracked by ExecPay. In other words, Southwell earned more than 62.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,685 out of 12,415 | 62nd |
Division Manufacturing | 1,945 out of 5,505 | 65th |
Major group Chemicals And Allied Products | 812 out of 2,375 | 66th |
Industry group Drugs | 725 out of 2,096 | 65th |
Industry Biological Products, Except Diagnostic Substances | 183 out of 449 | 59th |
Source: SEC filing on April 25, 2023.
Southwell's colleagues
We found two more compensation records of executives who worked with David Southwell at TScan Therapeutics in 2021.